Having worked it the vaccine/drug development field for many years, I would sadly say to the OP that the true reason is that rabies is a rare infection, and it’s not particularly contagious in humans, so there’s no profit in developing a treatment. Vaccines are generally easier to develop, and you have an unending market for them, so a vaccine is considered good enough.
Latest Answers